AstraZeneca

ESMO Berlin 2025
Biotech

ESMO: The ADC 'rollercoaster' rides on with next-gen meds

From Roche’s $1.4 billion licensing deal to an avalanche of clinical readouts, ADCs dominated Europe’s leading cancer conference over the weekend.
James Waldron Oct 21, 2025 3:00am
ESMO AstraZeneca

ESMO: AstraZeneca data 'validate' focus on in-house ADCs

Oct 18, 2025 12:55pm
arrow target quiver aim shoot ammo

AstraZeneca pens fresh IBD collab with Immunai worth $85M

Oct 16, 2025 9:00am
AZ

AstraZeneca: Building a transparent pipeline from the ground up

Oct 10, 2025 9:52am
AZ

Turbine looks to turbocharge AstraZeneca's ADC discovery

Oct 9, 2025 6:00am
An arrow incrementally going up stairs before pointing straight up Blue background

AstraZeneca's $1.3B bet yields 2nd phase 3 blood pressure win

Oct 7, 2025 4:01am